Journal
CURRENT NEUROPHARMACOLOGY
Volume 7, Issue 3, Pages 160-179Publisher
BENTHAM SCIENCE PUBL LTD
DOI: 10.2174/157015909789152146
Keywords
-
Categories
Funding
- Epilepsy Research UK
- Medical Research Council
- Research into Ageing
- Wellcome Trust
- Medical Research Council [G0500198] Funding Source: researchfish
- MRC [G0500198] Funding Source: UKRI
Ask authors/readers for more resources
Eighty years ago Drury & Szent-Gyorgyi described the actions of adenosine, AMP (adenylic acid) and ATP (pyrophosphoric or diphosphoric ester of adenylic acid) on the mammalian cardiovascular system, skeletal muscle, intestinal and urinary systems. Since then considerable insight has been gleaned on the means by which these compounds act, not least of which in the distinction between the two broad classes of their respective receptors, with their many subtypes, and the ensuing diversity in cellular consequences their activation invokes. These myriad actions are of course predicated on the release of the purines into the extracellular milieu, but, surprisingly, there is still considerable ambiguity as to how this occurs in various physiological and pathophysiological conditions. In this review we summarise the release of ATP and adenosine during seizures and cerebral ischemia and discuss mechanisms by which the purines adenosine and ATP may be released from cells in the CNS under these conditions.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available